| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$131,103 |
|
|
|
Indirect Value
|
$114,705 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$245,808 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-20 |
4 |
AS |
$45.28 |
$393,936 |
I/I |
(8,700) |
234,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-21 |
4 |
AS |
$43.60 |
$198,965 |
I/I |
(4,500) |
229,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-22 |
4 |
AS |
$42.74 |
$201,832 |
I/I |
(4,600) |
225,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-12 |
4 |
AS |
$46.17 |
$46,314 |
I/I |
(1,000) |
224,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-15 |
4 |
AS |
$41.87 |
$185,956 |
I/I |
(4,400) |
219,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-16 |
4 |
AS |
$41.75 |
$184,792 |
I/I |
(4,400) |
215,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-26 |
4 |
AS |
$39.72 |
$176,448 |
I/I |
(4,400) |
210,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4 |
AS |
$36.63 |
$155,421 |
I/I |
(4,200) |
206,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4/A |
AS |
$38.40 |
$7,680 |
I/I |
(200) |
206,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-03-27 |
4 |
AS |
$38.40 |
$7,680 |
D/D |
(200) |
206,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-04-11 |
4 |
AS |
$40.77 |
$179,628 |
I/I |
(4,400) |
202,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-04-12 |
4 |
AS |
$42.63 |
$188,844 |
I/I |
(4,400) |
197,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-04-26 |
4 |
AS |
$41.99 |
$185,427 |
I/I |
(4,400) |
193,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-04-27 |
4 |
AS |
$42.63 |
$188,232 |
I/I |
(4,400) |
188,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-09 |
4 |
AS |
$38.35 |
$172,305 |
I/I |
(4,400) |
184,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-10 |
4 |
AS |
$40.08 |
$178,332 |
I/I |
(4,400) |
180,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-21 |
4 |
AS |
$51.67 |
$231,441 |
I/I |
(4,400) |
175,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-22 |
4 |
AS |
$50.88 |
$223,872 |
I/I |
(4,400) |
171,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-05 |
4 |
AS |
$49.51 |
$218,756 |
I/I |
(4,400) |
166,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-06 |
4 |
AS |
$46.53 |
$208,532 |
I/I |
(4,400) |
162,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-26 |
4 |
AS |
$40.01 |
$177,370 |
I/I |
(4,400) |
158,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-27 |
4 |
AS |
$37.57 |
$76,055 |
I/I |
(2,000) |
156,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-09 |
4 |
AS |
$39.88 |
$1,198,006 |
I/I |
(30,000) |
126,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-10 |
4 |
AS |
$39.93 |
$1,137,733 |
I/I |
(28,400) |
97,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-26 |
4 |
AS |
$39.02 |
$152,221 |
I/I |
(3,900) |
93,778 |
0 |
- |
|
209 Records found
|
|
Page 6 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
